0000899243-18-019328.txt : 20180703 0000899243-18-019328.hdr.sgml : 20180703 20180703190237 ACCESSION NUMBER: 0000899243-18-019328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180701 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Satvat Ali J. CENTRAL INDEX KEY: 0001621788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38533 FILM NUMBER: 18939047 MAIL ADDRESS: STREET 1: C/O KOHLBERG KRAVIS ROBERTS & CO. STREET 2: 2800 SAND HILL ROAD, SUITE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eidos Therapeutics, Inc. CENTRAL INDEX KEY: 0001731831 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463733671 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-391-9740 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-01 0 0001731831 Eidos Therapeutics, Inc. EIDX 0001621788 Satvat Ali J. C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 1 0 1 0 Stock Option (right to buy) 20.34 2018-07-01 4 A 0 43056 0.00 A 2028-06-30 Common Stock 43056 43056 D The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 43,056 stock options (the "Grant") on July 2, 2018. The Grant shall vest as follows: one-third of the stock options shall vest annually over a period of three (3) years following June 29, 2018 subject to the Reporting Person's continued service to the Issuer through each vesting date. /s/Franco Valle, as Attorney-in-Fact 2018-07-03